Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kalapurakal, J. A.
Right arrow Articles by Marymont, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalapurakal, J. A.
Right arrow Articles by Marymont, M. H.
(Radiology. 2001;218:157-161.)
© RSNA, 2001

Radiation Oncology

Repositioning Accuracy with the Laitinen Frame for Fractionated Stereotactic Radiation Therapy in Adult and Pediatric Brain Tumors: Preliminary Report1

John A. Kalapurakal, MD, Zainab Ilahi, MD, Alan G. Kepka, PhD, Tomasz Bista, CMD, Stewart Goldman, MD, Tadanori Tomita, MD and Maryanne H. Marymont, MD

1 From the Divisions of Radiation Oncology (J.A.K., Z.I., A.G.K., T.B., M.H.M.), Pediatric Oncology (S.G.), and Pediatric Neurosurgery (T.T.), Northwestern Memorial Hospital, 251 E Huron St, L-178, Chicago, IL 60611. From the 1999 RSNA scientific assembly. Received December 1, 1999; revision requested January 28, 2000; final revision received April 3; accepted May 11. Address correspondence to J.A.K..

PURPOSE: To determine the repositioning accuracy, patient tolerance, and clinical efficacy of stereotactic radiation therapy for brain tumors in children and adults performed with the Laitinen stereotactic localizer and head holder.

MATERIALS AND METHODS: In this retrospective analysis, stereotactic frame tolerance was assessed by recording patient discomfort or pain in the ear and nose during each treatment in 34 patients, including 21 children and 13 adults with 37 lesions treated with fractionated stereotactic radiation therapy. Radiation doses ranged from 10–60 Gy at 1.0–4.0 Gy per fraction. Repositioning accuracy was assessed by comparing portal radiographs with setup fields on computed tomographic (CT) scout images. Clinical efficacy was assessed by analyzing posttreatment CT and magnetic resonance images.

RESULTS: The stereotactic localizer was well tolerated. The mean isocenter shifts observed after studying 305 portal radiographs were x-coordinate shift of 1.0 mm ± 0.7 (SD), y-coordinate shift of 0.8 mm ± 0.8, and z-coordinate shift of 1.7 mm ± 1.0. At a median follow-up of 16 months, local control was achieved in 18 of 22 primary and in one of eight of recurrent tumors.

CONCLUSION: The Laitinen stereotactic localizer is well tolerated with accurate reproducibility during stereotactic radiation therapy. Preliminary local control rates are consistent with those in other reports.

Index terms: Brain neoplasms, 10.31, 10.32, 10.33, 10.36 • Brain neoplasms, therapeutic radiology, 10.1267, 10.1269 • Computed tomography (CT), treatment planning, 10.12112, 10.1267 • Magnetic resonance (MR), treatment planning, 10.121412, 10.1267 • Radiations, protective and therapeutic agents and devices • Stereotaxis, 10.1267